
Need professional-grade analysis? Visit stockanalysis.com
$32.26B
0.18
6,309
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Integrated Diagnostics Holdings PLC (IDHC) Price Performance
Integrated Diagnostics Holdings PLC (IDHC) trades on London Stock Exchange in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $0.55, down 8.79% from the previous close.
Over the past year, IDHC has traded between a low of $0.30 and a high of $0.79. The stock has gained 77.8% over this period. It is currently 31.0% below its 52-week high.
Integrated Diagnostics Holdings PLC has a market capitalization of $32.26B, with a price-to-earnings ratio of 0.18.
About Integrated Diagnostics Holdings PLC
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities. It operates in Egypt, Sudan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is based in Saint Helier, Jersey.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- London Stock Exchange
- Currency
- USD
- Country
- United Kingdom
Financial Metrics
- Revenue (TTM)
- $6.76B
- EBITDA
- $2.22B
- Profit Margin
- 17.82%
- EPS (TTM)
- 0.03
- Book Value
- 5.37
Technical Indicators
- 52 Week High
- $0.84
- 52 Week Low
- $0.28
- 50 Day MA
- $0.64
- 200 Day MA
- $0.54
- Beta
- 0.28
Valuation
- Trailing P/E
- 0.18
- Forward P/E
- 12.89
- Price/Sales
- 3.02
- Price/Book
- 6.23
- Enterprise Value
- $317.29M